STOCK TITAN

H.B. Fuller Board Unanimously Rejects Unsolicited Proposal from Ancora

(Neutral)
(Positive)
Tags

Key Terms

organic growth financial
Organic growth is the increase in a company's sales or profits that comes from its own activities, such as selling more products or services, rather than through acquisitions or mergers. It is like a plant growing taller on its own, without needing outside help. For investors, it indicates the company's ability to expand steadily and sustainably through its existing business efforts.
ebitda financial
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.
View in glossary
dis-synergies financial
Dis-synergies are the negative effects that occur when two businesses, teams, systems, or products are combined and the result is worse than the parts on their own—think two puzzle pieces that don’t fit and create gaps. For investors, dis-synergies matter because they can erase expected gains from mergers or partnerships by increasing costs, reducing revenue, slowing operations, or causing customer or employee loss, which lowers future cash flow and raises risk.
adjusted ebitda margin financial
Adjusted EBITDA margin shows how much profit a company makes from its core operations, expressed as a percentage of its total revenue, after removing certain one-time or unusual expenses and income. It helps investors understand the company's true earning ability from regular business activities, making it easier to compare performance over time or with other companies. Think of it as measuring the efficiency of a business in turning sales into profits, excluding irregular adjustments.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Board Determined Proposal Significantly Undervalues the BAS Business, Ignores Its Future Growth Prospects, and Lacks Critical Details to Make It Actionable

ST. PAUL, Minn.--(BUSINESS WIRE)-- H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world’s largest pureplay adhesives company, today announced that, following a thorough review supported by independent financial and legal advisors, its Board of Directors has unanimously rejected Ancora’s unsolicited, non-binding proposal to acquire its Building Adhesives Solutions (“BAS”) business.

The full text of H.B. Fuller’s Board's response letter is set forth below.

Dear Fredrick and Jim,

H.B. Fuller’s Board of Directors has carefully evaluated Ancora’s proposal to purchase the BAS business segment with the support of our independent financial and legal advisors. After careful consideration, the Board has determined that the proposal materially undervalues the BAS business, ignores its prospects for future growth and value creation, fails to appreciate the importance of this segment to our leading pure play adhesives platform, and lacks key details needed to demonstrate Ancora’s ability to execute any such transaction.

In reviewing the proposal, our Board concluded the following:

  • The proposal significantly undervalues the BAS business: The $1.1 billion to $1.2 billion value proposed is substantially below precedent transactions and doesn’t represent full value for the business.
  • The BAS business is expected to be a significant driver of earnings moving forward: In the second quarter, BAS demonstrated its performance momentum by delivering organic growth of 6% year-over-year, driven by strong pricing and volumes, and a 10% EBITDA improvement, reflecting the operating leverage we are able to generate in this business. As key construction end markets recover and benefit from tailwinds such as the data center buildout, we expect BAS to be a significant driver of earnings moving forward.
  • Project Quantum Leap is further strengthening our competitive positioning in BAS: Through continued footprint rationalization, we expect a step change in the earnings power of BAS over the near-term as we continue to expand penetration of our leading product lines.
  • The proposal would result in significant dis-synergies: A carve out of the BAS business, which shares manufacturing with H.B. Fuller’s other businesses in over thirty plants around the world, would result in material operating inefficiencies. After considering tax and other dis-synergies, the benefits of leverage reduction are materially offset by diminished growth, cashflow, and scale.
  • The Company has multiple levers to facilitate rapid deleveraging: Given H.B. Fuller’s strong cash flow generation, the Board is confident in management’s ability to bring leverage back within its target range of 2.5x to 3.0x within two years following the completion of the Advanced Medical Solutions (“AMS”) transaction.
  • Ancora’s proposal lacks critical details to make it actionable. Ancora’s proposal lacks detail on its ability to finance the transaction or operate BAS without continuous support from the Company.

The Company’s focus today is on closing and integrating the acquisition of AMS, continuing to advance Project Quantum Leap, and executing ongoing initiatives to drive commercial and manufacturing excellence. H.B. Fuller’s Board is confident that the Company’s management team is well positioned to advance these actions, which will meaningfully enhance portfolio mix, accelerate the path to achieving greater than 20% adjusted EBITDA margin, and create sustainable value for shareholders over the near- and long-term.

H.B. Fuller’s Board is always open to opportunities to enhance shareholder value. We regularly review the Company’s portfolio with an emphasis on maximizing shareholder value, and we will continue to evaluate the entire company as well as individual business units through this lens.

Sincerely,

Teresa J. Rasmussen
Chair of the Board
On behalf of the Board of Directors

About H.B. Fuller

As the largest pureplay adhesives company in the world, H.B. Fuller’s (NYSE: FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2025 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,100 global team members who collaborate with customers across more than 30 market segments in 150 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets. Learn more at www.hbfuller.com.

Investors:
Scott Jensen
investors@hbfuller.com

Media:
Nick Capuano / Liz Cohen
Kekst CNC
Keksthbfuller@kekstcnc.com

Source: H.B. Fuller Company